Search Results
Results found for "GIO Therapeutics"
- A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.
crystal structures of both CBRs.[4–8] A key challenge in CBR modulator development is separating the therapeutic New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders.
- Fluorescence based HTS compatible ligand binding assays for dopamine D3 receptors in baculovirus preparations and live cells
have been approved as drugs, however they often have serious side effects and too low or temporary therapeutic Pharmacology & Therapeutics 2016 , 165 , 164–177. https://doi.org/10.1016/j.pharmthera.2016.06.007
- Unlocking Cell's Secrets: Spontaneous β-Arrestin-Membrane Preassociation Drives Receptor-Activation
Pharmacology & therapeutics, 89(2), 139–147. https://doi.org/10.1016/s0163-7258(00)00107-8
- Feeder or trigger – CCR2 as a scavenger and regulator of cell migration
This scavenging function should be considered when evaluating the safety and therapeutic efficacy of
- Decoding β-Arrestins: from Structure to function
within distinct cell types or tissues, will undoubtedly provide valuable guidance for advancing such therapeutic
- Structural landscape of the Chemokine Receptor system
binding and receptor activation will pave the way for significant advancements in the development of therapeutics
